Mary E. Lajiness

715 total citations
11 papers, 596 citations indexed

About

Mary E. Lajiness is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, Mary E. Lajiness has authored 11 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 2 papers in Spectroscopy. Recurrent topics in Mary E. Lajiness's work include Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Mary E. Lajiness is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Mary E. Lajiness collaborates with scholars based in United States, Canada and Germany. Mary E. Lajiness's co-authors include Rita M. Huff, Christopher L. Chio, Helmut A. Ensinger, Joachim Mierau, Isabella H. Wulur, Thomas D. Barber, Martin Smith, J. Neil Duncan, Dac M. Dinh and Melinda D. Willard and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Mary E. Lajiness

11 papers receiving 565 citations

Peers

Mary E. Lajiness

CMN

MB

NEURO

PMH

OC

Christopher L. Chio United States

Keith R. Jarvie Canada

Mia Engström Finland

Philip F. Morgan United States

Joachim Mierau Germany

Frederik C. Grønvald Denmark

Kazuo Koshiya Japan

Martyn C. Coldwell United Kingdom

Sean P. Moran United States

Miyuki Ota Japan

Christopher L. Chio United States

Mary E. Lajiness

247 ×0.7

CMN

233 ×0.7

MB

93 ×0.9

NEURO

44 ×0.7

PMH

34 ×0.6

OC

Citations per year, relative to Mary E. Lajiness Mary E. Lajiness (= 1×) peers Christopher L. Chio

Countries citing papers authored by Mary E. Lajiness

Since Specialization

Citations

This map shows the geographic impact of Mary E. Lajiness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Lajiness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Lajiness more than expected).

Fields of papers citing papers by Mary E. Lajiness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Lajiness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Lajiness. The network helps show where Mary E. Lajiness may publish in the future.

Co-authorship network of co-authors of Mary E. Lajiness

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Lajiness. A scholar is included among the top collaborators of Mary E. Lajiness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Lajiness. Mary E. Lajiness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Heinz, Beverly A., et al.. (2015). Phospho-ERK Assays. Europe PMC (PubMed Central). 1 indexed citations

2.

Esseltine, Jessica L., Melinda D. Willard, Isabella H. Wulur, et al.. (2013). Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling. Molecular Pharmacology. 83(4). 770–780. 24 indexed citations

3.

Willard, Melinda D., Mary E. Lajiness, Isabella H. Wulur, et al.. (2012). Somatic Mutations in CCK2R Alter Receptor Activity that Promote Oncogenic Phenotypes. Molecular Cancer Research. 10(6). 739–749. 15 indexed citations

4.

Heinz, Beverly A., et al.. (2012). IP-3/IP-1 Assays. 1 indexed citations

5.

Heinz, Beverly A., et al.. (2012). Impedance-Based Technologies. 3 indexed citations

6.

Haadsma‐Svensson, Susanne R., Dac M. Dinh, J. Neil Duncan, et al.. (2001). Dopamine D₃ Receptor Antagonists. 1. Synthesis and Structure−Activity Relationships of 5,6-Dimethoxy-N-alkyl- and N-Alkylaryl-Substituted 2-Aminoindans. Journal of Medicinal Chemistry. 44(26). 4716–4732. 37 indexed citations

7.

Poel, Toni J., Dac M. Dinh, Mary E. Lajiness, et al.. (1997). Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor. European Journal of Pharmacology. 322(2-3). 283–286. 21 indexed citations

8.

Mierau, Joachim, et al.. (1995). Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. European Journal of Pharmacology Molecular Pharmacology. 290(1). 29–36. 217 indexed citations

9.

Lajiness, Mary E., et al.. (1995). Signaling Mechanisms of D2, D3, and D4 Dopamine Receptors Determined in Transfected Cell Lines. Clinical Neuropharmacology. 18. S25–S33. 14 indexed citations

10.

Lajiness, Mary E., et al.. (1994). Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.. Molecular Pharmacology. 45(1). 51–60. 212 indexed citations

11.

Lajiness, Mary E., et al.. (1993). D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1573–1581. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact